Emily
Editor, Senior Moderator
https://www.medscape.com/viewarticle/930834#vp_1
Advanced Prostate Cancers Still Rising in US
How Long Until a Plateau?
Nick Mulcahy
May 20, 2020
The incidence of advanced prostate cancers in the United States "persistently" increased annually for 5 years after the United States Preventive Services Task Force (USPSTF) controversially advised in 2012 against prostate-specific antigen (PSA) screening in men of all ages, new research indicates.
But a biostatistician not involved with the study said the USPSTF's recommendation is not wholly to blame because "you need 5 to 7 years of lag time at a minimum to influence PSA screening," and suggested that other factors were also at play...
Advanced Prostate Cancers Still Rising in US
How Long Until a Plateau?
Nick Mulcahy
May 20, 2020
The incidence of advanced prostate cancers in the United States "persistently" increased annually for 5 years after the United States Preventive Services Task Force (USPSTF) controversially advised in 2012 against prostate-specific antigen (PSA) screening in men of all ages, new research indicates.
But a biostatistician not involved with the study said the USPSTF's recommendation is not wholly to blame because "you need 5 to 7 years of lag time at a minimum to influence PSA screening," and suggested that other factors were also at play...
